Bio-Rad Laboratories has launched a range of anti-idiotypic antibodies targeting the immune checkpoint inhibitor drugs pembrolizumab (Keytruda) and nivolumab (Opdivo). Anti-pembrolizumab and anti-nivolumab antibodies are designed for use in bioanalytical assays to monitor the drug levels in cancer patients.
Bio-Rad's anti-vedolizumab antibodies include four recombinant monoclonal anti-idiotypic antibodies that are highly specific for the humanised IgG1 kappa antibody drug vedolizumab, and are suitable for development of bioanalytical and patient monitoring assays.
Bio-Rad Laboratories has announced the StarBright Blue 520 Fluorescent Secondary Antibodies — fluorescent dye-labelled secondary antibodies for use in multiplex western blotting.
Fresche Bioscience has signed an agreement to support manufacture of Stayzon's range of antimicrobial coatings and ancillary treatments.
Made from tiny nanorods, the newly developed 'NanoZymes' use visible light to create highly reactive oxygen species that rapidly break down and kill bacteria.
Nupherin, from Enzo Life Sciences, is a peptide-based transfection reagent that combines a non-classical nuclear localisation sequence (M9) with a nucleotide binding domain, thereby helping to transport DNA into the transfected cell's nucleus.
AdipoGen Life Sciences' anti-α-Tubulin monoclonal antibodies (recombinant) are composed of human variable regions (VH and VL) (λ-chain) of immunoglobulin fused to the human lgG2 Fc domain.
Mercury poisoning through artisanal and small-scale gold mining is increasing — but Dr Justin Chalker believes that chemists can provide cheap and effective solutions to curb the damage.
Advanced Analytical Technology's line of High Sensitivity Fragment Analysis Kits for its Fragment Analyzer Automated Capillary Electrophoresis System can measure the size and concentration of the three common cfDNA fragments using only 2 mL of sample.
EpiGentek has released a monoclonal antibody that is specific to Staphylococcus aureus Cas9 (SaCas9) and enables easy and specific monitoring of gene editing processes.
CHROMagar COL-APSE is a sensitive and specific medium for the selective growth of colistin-resistant bacterial pathogens.
Fertility group Genea has announced an updated version of its culture medium Gems, which is claimed to result in more high-grade embryos per IVF cycle than traditional products.
Abcam has combined the advantages of its RabMAb rabbit monoclonals with recombinant technology to deliver high-performance antibodies.
ProSci's Risk-Free Antibody Sets consist of several monoclonal antibodies (20 µg each) against a single target, allowing selection of the best clone for specific applications. Antibodies were developed using recombinant proteins expressed in mammalian cells to best recognise the native proteins.